Redhill Biopharma
Yahoo Finance • 25 days ago
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
LAS VEGAS, March 2, 2026 /PRNewswire/ -- The biliary tract cancer market is experiencing steady growth driven by rising global incidence and improved diagnostic capabilities. Increasing adoption of targeted therapies and immuno-oncology ap... Full story
Yahoo Finance • 4 months ago
RedHill Biopharma regains Nasdaq stockholders’ equity compliance
* RedHill Biopharma (RDHL [https://seekingalpha.com/symbol/RDHL]) has regained compliance [https://seekingalpha.com/pr/20323207-redhill-biopharma-successfully-regains-compliance-with-nasdaq-stockholders-equity-requirement] with Nasdaq as... Full story
Yahoo Finance • 7 months ago
RedHill received Talicia licensing payments totaling $1.1 million
* RedHill Biopharma (NASDAQ:RDHL [https://seekingalpha.com/symbol/RDHL]) on Monday announced that it has received its first Talicia ex-U.S. sales milestone, royalties and other payments totaling approximately $1.1 million. * Talicia is... Full story
Yahoo Finance • 9 months ago
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
Health care stocks advanced late Tuesday afternoon, with the NYSE Health Care Index and the Health C PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 2 years ago
Morning Brew: Bank of America Predicts S&P 500 Upside, Kraft Heinz Approves $3B Buyback
Bank of America's global research team has outlined 10 key investment themes for 2024, forecasting a 10% rise in the S&P 500 (SP500), alongside potential interest rate cuts and Brent oil averaging $90 per barrel. The themes include a globa... Full story
Yahoo Finance • 3 years ago
RedHill Initiates First Community-Setting Warranty Program to Refund Talicia Non-Responders
RedHill commits to reimburse out-of-pocket costs for Talicia patients that complete the full 14-day treatment course and whose infection is not eradicated based on post-treatment confirmation testing - warranty commitment extends to all co... Full story
Yahoo Finance • 3 years ago
RedHill Biopharma Announces Plan to Implement ADS Ratio Change
TEL AVIV, Israel and RALEIGH, NC, March 16, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it plans to implement a ratio change of the Co... Full story
Yahoo Finance • 3 years ago
RedHill Biopharma Ltd Announces RedHill's RHB-102 Positive MHRA Meeting & MAA Plan
RedHill Announces Positive MHRA Meeting and Planned UK Marketing Authorisation Application of RHB-102 (BEKINDA®) for Oncology Support UK MHRA scientific advice meeting deems RHB-102 (BEKINDA®) data supportive of submission for approval fo... Full story
Yahoo Finance • 3 years ago
RedHill Announces Positive MHRA Meeting and Planned UK Marketing Authorisation Application of RHB-102 (BEKINDA®) for Oncology Support
UK MHRA scientific advice meeting deems RHB-102 (BEKINDA®) data supportive of submission for approval for chemotherapy and radiotherapy induced nausea and vomiting (CINV/RINV) RHB-102 UK Marketing Authorisation Application (MAA) submission... Full story
Yahoo Finance • 3 years ago
RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
TEL AVIV, Israel & RALEIGH, N.C., Oct. 18, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, announces that on October 12, 2022, it received a letter from the Li... Full story
